nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Vitamin A—RBP4—polycystic ovary syndrome	0.0155	0.786	CrCbGaD
Isotretinoin—Emotional distress—Metformin—polycystic ovary syndrome	0.0108	0.0503	CcSEcCtD
Isotretinoin—RXRG—pituitary gland—polycystic ovary syndrome	0.0108	0.0475	CbGeAlD
Isotretinoin—RXRG—adipose tissue—polycystic ovary syndrome	0.0108	0.0473	CbGeAlD
Isotretinoin—RXRA—female gonad—polycystic ovary syndrome	0.0102	0.0451	CbGeAlD
Isotretinoin—RARB—adrenal gland—polycystic ovary syndrome	0.00987	0.0434	CbGeAlD
Isotretinoin—RXRG—adrenal gland—polycystic ovary syndrome	0.00965	0.0425	CbGeAlD
Isotretinoin—RXRA—endocrine gland—polycystic ovary syndrome	0.00953	0.0419	CbGeAlD
Isotretinoin—RARA—endometrium—polycystic ovary syndrome	0.00936	0.0412	CbGeAlD
Isotretinoin—RARB—female gonad—polycystic ovary syndrome	0.0092	0.0405	CbGeAlD
Isotretinoin—RARG—uterus—polycystic ovary syndrome	0.00918	0.0404	CbGeAlD
Isotretinoin—RARB—vagina—polycystic ovary syndrome	0.00915	0.0403	CbGeAlD
Isotretinoin—RXRB—adrenal gland—polycystic ovary syndrome	0.00907	0.0399	CbGeAlD
Isotretinoin—RARG—adipose tissue—polycystic ovary syndrome	0.00898	0.0395	CbGeAlD
Isotretinoin—RARA—uterus—polycystic ovary syndrome	0.00863	0.038	CbGeAlD
Isotretinoin—RARB—endocrine gland—polycystic ovary syndrome	0.00856	0.0377	CbGeAlD
Isotretinoin—RARA—pituitary gland—polycystic ovary syndrome	0.00847	0.0373	CbGeAlD
Isotretinoin—RXRB—female gonad—polycystic ovary syndrome	0.00846	0.0372	CbGeAlD
Isotretinoin—RARA—adipose tissue—polycystic ovary syndrome	0.00844	0.0371	CbGeAlD
Isotretinoin—RXRB—vagina—polycystic ovary syndrome	0.00841	0.037	CbGeAlD
Isotretinoin—RXRG—endocrine gland—polycystic ovary syndrome	0.00837	0.0368	CbGeAlD
Isotretinoin—Acidosis—Metformin—polycystic ovary syndrome	0.00831	0.0386	CcSEcCtD
Isotretinoin—Hypothermia—Metformin—polycystic ovary syndrome	0.00821	0.0381	CcSEcCtD
Isotretinoin—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00821	0.0381	CcSEcCtD
Isotretinoin—RARG—adrenal gland—polycystic ovary syndrome	0.00805	0.0354	CbGeAlD
Isotretinoin—RXRB—endocrine gland—polycystic ovary syndrome	0.00787	0.0346	CbGeAlD
Isotretinoin—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00783	0.0363	CcSEcCtD
Isotretinoin—RARA—adrenal gland—polycystic ovary syndrome	0.00757	0.0333	CbGeAlD
Isotretinoin—RARG—female gonad—polycystic ovary syndrome	0.00751	0.033	CbGeAlD
Isotretinoin—RARG—vagina—polycystic ovary syndrome	0.00746	0.0328	CbGeAlD
Isotretinoin—Respiratory distress—Metformin—polycystic ovary syndrome	0.00725	0.0336	CcSEcCtD
Isotretinoin—Nail disorder—Metformin—polycystic ovary syndrome	0.0071	0.033	CcSEcCtD
Isotretinoin—RARA—female gonad—polycystic ovary syndrome	0.00706	0.0311	CbGeAlD
Isotretinoin—Upset stomach—Metformin—polycystic ovary syndrome	0.00702	0.0326	CcSEcCtD
Isotretinoin—RARA—endocrine gland—polycystic ovary syndrome	0.00657	0.0289	CbGeAlD
Isotretinoin—Contusion—Metformin—polycystic ovary syndrome	0.00528	0.0245	CcSEcCtD
Isotretinoin—Chest discomfort—Metformin—polycystic ovary syndrome	0.0052	0.0242	CcSEcCtD
Isotretinoin—Lightheadedness—Metformin—polycystic ovary syndrome	0.00412	0.0191	CcSEcCtD
Isotretinoin—Ear pain—Metformin—polycystic ovary syndrome	0.00392	0.0182	CcSEcCtD
Isotretinoin—Nasal congestion—Metformin—polycystic ovary syndrome	0.00367	0.017	CcSEcCtD
Isotretinoin—Renal impairment—Metformin—polycystic ovary syndrome	0.00351	0.0163	CcSEcCtD
Isotretinoin—Lethargy—Metformin—polycystic ovary syndrome	0.00341	0.0158	CcSEcCtD
Isotretinoin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00334	0.0155	CcSEcCtD
Isotretinoin—Dehydration—Metformin—polycystic ovary syndrome	0.00311	0.0144	CcSEcCtD
Isotretinoin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00299	0.0139	CcSEcCtD
Isotretinoin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00291	0.0135	CcSEcCtD
Isotretinoin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00283	0.0131	CcSEcCtD
Isotretinoin—Sweating increased—Metformin—polycystic ovary syndrome	0.00281	0.0131	CcSEcCtD
Isotretinoin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00277	0.0129	CcSEcCtD
Isotretinoin—Neutropenia—Metformin—polycystic ovary syndrome	0.0027	0.0125	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00268	0.0125	CcSEcCtD
Isotretinoin—Infestation—Metformin—polycystic ovary syndrome	0.00257	0.012	CcSEcCtD
Isotretinoin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00257	0.012	CcSEcCtD
Isotretinoin—Drowsiness—Metformin—polycystic ovary syndrome	0.00257	0.012	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00252	0.0117	CcSEcCtD
Isotretinoin—Hepatitis—Metformin—polycystic ovary syndrome	0.00231	0.0107	CcSEcCtD
Isotretinoin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0023	0.0107	CcSEcCtD
Isotretinoin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00228	0.0106	CcSEcCtD
Isotretinoin—Eye disorder—Metformin—polycystic ovary syndrome	0.00216	0.01	CcSEcCtD
Isotretinoin—Vitamin A—CYP1A1—polycystic ovary syndrome	0.00215	0.109	CrCbGaD
Isotretinoin—Flushing—Metformin—polycystic ovary syndrome	0.00215	0.00996	CcSEcCtD
Isotretinoin—Angiopathy—Metformin—polycystic ovary syndrome	0.0021	0.00974	CcSEcCtD
Isotretinoin—Chills—Metformin—polycystic ovary syndrome	0.00207	0.00963	CcSEcCtD
Isotretinoin—Tretinoin—CYP1A1—polycystic ovary syndrome	0.00207	0.105	CrCbGaD
Isotretinoin—Malnutrition—Metformin—polycystic ovary syndrome	0.00201	0.00934	CcSEcCtD
Isotretinoin—Erythema—Metformin—polycystic ovary syndrome	0.00201	0.00934	CcSEcCtD
Isotretinoin—Flatulence—Metformin—polycystic ovary syndrome	0.00198	0.00921	CcSEcCtD
Isotretinoin—Vision blurred—Metformin—polycystic ovary syndrome	0.0019	0.00881	CcSEcCtD
Isotretinoin—Tremor—Metformin—polycystic ovary syndrome	0.00189	0.00875	CcSEcCtD
Isotretinoin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00187	0.00867	CcSEcCtD
Isotretinoin—Malaise—Metformin—polycystic ovary syndrome	0.00181	0.00843	CcSEcCtD
Isotretinoin—Syncope—Metformin—polycystic ovary syndrome	0.0018	0.00838	CcSEcCtD
Isotretinoin—Palpitations—Metformin—polycystic ovary syndrome	0.00178	0.00826	CcSEcCtD
Isotretinoin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00177	0.00821	CcSEcCtD
Isotretinoin—Hypertension—Metformin—polycystic ovary syndrome	0.00174	0.00807	CcSEcCtD
Isotretinoin—Myalgia—Metformin—polycystic ovary syndrome	0.00171	0.00795	CcSEcCtD
Isotretinoin—Chest pain—Metformin—polycystic ovary syndrome	0.00171	0.00795	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0017	0.0079	CcSEcCtD
Isotretinoin—Discomfort—Metformin—polycystic ovary syndrome	0.00169	0.00786	CcSEcCtD
Isotretinoin—Oedema—Metformin—polycystic ovary syndrome	0.00164	0.00763	CcSEcCtD
Isotretinoin—Infection—Metformin—polycystic ovary syndrome	0.00163	0.00758	CcSEcCtD
Isotretinoin—Shock—Metformin—polycystic ovary syndrome	0.00162	0.0075	CcSEcCtD
Isotretinoin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00161	0.00748	CcSEcCtD
Isotretinoin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00161	0.00747	CcSEcCtD
Isotretinoin—Skin disorder—Metformin—polycystic ovary syndrome	0.0016	0.00741	CcSEcCtD
Isotretinoin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00159	0.00737	CcSEcCtD
Isotretinoin—Anorexia—Metformin—polycystic ovary syndrome	0.00157	0.00727	CcSEcCtD
Isotretinoin—Hypotension—Metformin—polycystic ovary syndrome	0.00153	0.00713	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0015	0.00695	CcSEcCtD
Isotretinoin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00147	0.00685	CcSEcCtD
Isotretinoin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00146	0.0068	CcSEcCtD
Isotretinoin—Somnolence—Metformin—polycystic ovary syndrome	0.00146	0.00678	CcSEcCtD
Isotretinoin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00145	0.00671	CcSEcCtD
Isotretinoin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00143	0.00663	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00142	0.00658	CcSEcCtD
Isotretinoin—Fatigue—Metformin—polycystic ovary syndrome	0.00142	0.00657	CcSEcCtD
Isotretinoin—Constipation—Metformin—polycystic ovary syndrome	0.0014	0.00652	CcSEcCtD
Isotretinoin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00135	0.00628	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00134	0.00624	CcSEcCtD
Isotretinoin—Urticaria—Metformin—polycystic ovary syndrome	0.0013	0.00606	CcSEcCtD
Isotretinoin—Abdominal pain—Metformin—polycystic ovary syndrome	0.0013	0.00603	CcSEcCtD
Isotretinoin—Asthenia—Metformin—polycystic ovary syndrome	0.00118	0.00547	CcSEcCtD
Isotretinoin—Pruritus—Metformin—polycystic ovary syndrome	0.00116	0.00539	CcSEcCtD
Isotretinoin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00112	0.00522	CcSEcCtD
Isotretinoin—Dizziness—Metformin—polycystic ovary syndrome	0.00109	0.00504	CcSEcCtD
Isotretinoin—Vomiting—Metformin—polycystic ovary syndrome	0.00104	0.00485	CcSEcCtD
Isotretinoin—Rash—Metformin—polycystic ovary syndrome	0.00104	0.00481	CcSEcCtD
Isotretinoin—Dermatitis—Metformin—polycystic ovary syndrome	0.00103	0.0048	CcSEcCtD
Isotretinoin—Headache—Metformin—polycystic ovary syndrome	0.00103	0.00478	CcSEcCtD
Isotretinoin—Nausea—Metformin—polycystic ovary syndrome	0.000975	0.00453	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—NCOR1—polycystic ovary syndrome	0.000802	0.00149	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000799	0.00149	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—LSM5—polycystic ovary syndrome	0.000793	0.00148	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—LSM5—polycystic ovary syndrome	0.000793	0.00148	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IRS1—polycystic ovary syndrome	0.00079	0.00147	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SAP30L—polycystic ovary syndrome	0.000784	0.00146	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—PPARG—polycystic ovary syndrome	0.000771	0.00143	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SAP30L—polycystic ovary syndrome	0.000769	0.00143	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000761	0.00141	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—INS—polycystic ovary syndrome	0.000756	0.00141	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000756	0.00141	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000752	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CDH15—polycystic ovary syndrome	0.000751	0.0014	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IRS1—polycystic ovary syndrome	0.000742	0.00138	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SAP30L—polycystic ovary syndrome	0.000737	0.00137	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SAP30L—polycystic ovary syndrome	0.000737	0.00137	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—SULT2A1—polycystic ovary syndrome	0.000733	0.00136	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IGF1—polycystic ovary syndrome	0.000732	0.00136	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TEAD2—polycystic ovary syndrome	0.000729	0.00136	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—PPARG—polycystic ovary syndrome	0.000725	0.00135	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000725	0.00135	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000724	0.00135	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000722	0.00134	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—INS—polycystic ovary syndrome	0.000711	0.00132	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000698	0.0013	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.000695	0.00129	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000692	0.00129	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IGF1—polycystic ovary syndrome	0.000688	0.00128	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—polycystic ovary syndrome	0.000685	0.00127	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000679	0.00126	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000677	0.00126	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000674	0.00125	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000671	0.00125	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TEAD2—polycystic ovary syndrome	0.000667	0.00124	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000662	0.00123	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—polycystic ovary syndrome	0.00066	0.00123	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.000659	0.00123	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TEAD2—polycystic ovary syndrome	0.000654	0.00122	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.000653	0.00121	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000649	0.00121	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000632	0.00118	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TEAD2—polycystic ovary syndrome	0.000627	0.00117	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TEAD2—polycystic ovary syndrome	0.000627	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000626	0.00116	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000622	0.00116	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000622	0.00116	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.000612	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—NCOR1—polycystic ovary syndrome	0.000603	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.000601	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.0006	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZNF430—polycystic ovary syndrome	0.000596	0.00111	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ZNF205—polycystic ovary syndrome	0.000596	0.00111	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	0.00059	0.0011	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000578	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—polycystic ovary syndrome	0.000574	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—CYP1A1—polycystic ovary syndrome	0.000571	0.00106	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00057	0.00106	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00057	0.00106	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00057	0.00106	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000567	0.00105	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000561	0.00104	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—polycystic ovary syndrome	0.000559	0.00104	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000543	0.00101	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000543	0.00101	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000542	0.00101	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000527	0.000981	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000527	0.000981	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—RPL37A—polycystic ovary syndrome	0.000519	0.000966	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ADARB1—polycystic ovary syndrome	0.000507	0.000943	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000506	0.00094	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000496	0.000922	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000491	0.000914	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—NR3C1—polycystic ovary syndrome	0.000488	0.000907	CbGpPWpGaD
Isotretinoin—RXRA—Organelle biogenesis and maintenance—NCOR1—polycystic ovary syndrome	0.000483	0.000898	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000478	0.000889	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—RPL37A—polycystic ovary syndrome	0.000475	0.000884	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000472	0.000877	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—RPL37A—polycystic ovary syndrome	0.000466	0.000867	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.00046	0.000856	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000453	0.000843	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000449	0.000836	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—RPL37A—polycystic ovary syndrome	0.000447	0.000831	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—RPL37A—polycystic ovary syndrome	0.000447	0.000831	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000443	0.000825	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IRS2—polycystic ovary syndrome	0.000443	0.000824	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000441	0.000821	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000441	0.00082	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—LEP—polycystic ovary syndrome	0.000434	0.000807	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000432	0.000804	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—PPARG—polycystic ovary syndrome	0.000432	0.000803	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.00043	0.000799	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	0.000423	0.000786	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000423	0.000786	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000423	0.000786	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—LSM5—polycystic ovary syndrome	0.000413	0.000769	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	0.000406	0.000756	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.0004	0.000743	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000397	0.000739	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000393	0.000731	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IRS1—polycystic ovary syndrome	0.000387	0.00072	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000385	0.000717	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—polycystic ovary syndrome	0.000385	0.000716	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SAP30L—polycystic ovary syndrome	0.000384	0.000715	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—PPARG—polycystic ovary syndrome	0.000378	0.000703	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000378	0.000702	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—INS—polycystic ovary syndrome	0.000371	0.000689	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000369	0.000687	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000369	0.000687	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000368	0.000684	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000364	0.000676	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IGF1—polycystic ovary syndrome	0.000358	0.000667	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000356	0.000663	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NMNAT3—polycystic ovary syndrome	0.000351	0.000654	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—YAP1—polycystic ovary syndrome	0.000348	0.000648	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000344	0.000641	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000342	0.000636	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000342	0.000636	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.00034	0.000633	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000335	0.000623	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IL6—polycystic ovary syndrome	0.00033	0.000615	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00033	0.000614	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000328	0.000609	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TEAD2—polycystic ovary syndrome	0.000327	0.000608	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000324	0.000603	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SUOX—polycystic ovary syndrome	0.000321	0.000598	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—LPCAT2—polycystic ovary syndrome	0.000321	0.000598	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—YAP1—polycystic ovary syndrome	0.000319	0.000593	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000317	0.00059	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—YAP1—polycystic ovary syndrome	0.000313	0.000581	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IL6—polycystic ovary syndrome	0.000311	0.000578	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000308	0.000573	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000307	0.000572	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PGR—polycystic ovary syndrome	0.000304	0.000566	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—YAP1—polycystic ovary syndrome	0.0003	0.000557	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—YAP1—polycystic ovary syndrome	0.0003	0.000557	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ISYNA1—polycystic ovary syndrome	0.000299	0.000556	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—POMC—polycystic ovary syndrome	0.000298	0.000554	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000292	0.000543	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	0.000291	0.000542	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000283	0.000527	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000282	0.000524	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000281	0.000523	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PGR—polycystic ovary syndrome	0.000278	0.000518	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000277	0.000516	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000276	0.000514	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000276	0.000513	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PGR—polycystic ovary syndrome	0.000273	0.000508	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000273	0.000507	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000265	0.000492	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000265	0.000492	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000264	0.000492	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000264	0.000492	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000263	0.00049	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PGR—polycystic ovary syndrome	0.000262	0.000487	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PGR—polycystic ovary syndrome	0.000262	0.000487	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000259	0.000481	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TEAD2—polycystic ovary syndrome	0.000254	0.000473	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKR1C2—polycystic ovary syndrome	0.000254	0.000473	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000254	0.000472	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000249	0.000463	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000244	0.000454	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—DLG4—polycystic ovary syndrome	0.000242	0.00045	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00024	0.000447	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00024	0.000446	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000238	0.000444	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000238	0.000444	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AR—polycystic ovary syndrome	0.000237	0.00044	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—RPL37A—polycystic ovary syndrome	0.000233	0.000433	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.00023	0.000428	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000227	0.000422	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000226	0.000421	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.00022	0.00041	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AR—polycystic ovary syndrome	0.000216	0.000402	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PNPLA2—polycystic ovary syndrome	0.000213	0.000396	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AR—polycystic ovary syndrome	0.000212	0.000395	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00021	0.000391	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NCOR1—polycystic ovary syndrome	0.000207	0.000385	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AR—polycystic ovary syndrome	0.000203	0.000378	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AR—polycystic ovary syndrome	0.000203	0.000378	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000202	0.000375	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—STAR—polycystic ovary syndrome	0.000193	0.000358	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000193	0.000358	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000192	0.000358	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NR3C1—polycystic ovary syndrome	0.000191	0.000356	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00019	0.000354	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NCOR1—polycystic ovary syndrome	0.000189	0.000352	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NCOR1—polycystic ovary syndrome	0.000185	0.000345	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000181	0.000337	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000178	0.000331	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NCOR1—polycystic ovary syndrome	0.000178	0.000331	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000178	0.000331	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR3C1—polycystic ovary syndrome	0.000175	0.000325	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000172	0.00032	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NR3C1—polycystic ovary syndrome	0.000172	0.000319	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HMMR—polycystic ovary syndrome	0.000172	0.000319	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NR3C1—polycystic ovary syndrome	0.000165	0.000306	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NR3C1—polycystic ovary syndrome	0.000165	0.000306	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000164	0.000304	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6—polycystic ovary syndrome	0.000162	0.000301	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000162	0.000301	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000162	0.0003	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—YAP1—polycystic ovary syndrome	0.000156	0.00029	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000153	0.000285	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—LHB—polycystic ovary syndrome	0.000149	0.000278	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—LEP—polycystic ovary syndrome	0.000149	0.000277	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PPARG—polycystic ovary syndrome	0.000148	0.000276	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000146	0.000271	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000141	0.000263	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000138	0.000257	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000138	0.000256	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PGR—polycystic ovary syndrome	0.000136	0.000254	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PPARG—polycystic ovary syndrome	0.000136	0.000252	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000134	0.000248	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PPARG—polycystic ovary syndrome	0.000133	0.000247	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SULT2A1—polycystic ovary syndrome	0.00013	0.000242	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PPARG—polycystic ovary syndrome	0.00013	0.000242	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PPARG—polycystic ovary syndrome	0.000127	0.000237	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PPARG—polycystic ovary syndrome	0.000127	0.000237	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—INS—polycystic ovary syndrome	0.000127	0.000237	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—RRM2—polycystic ovary syndrome	0.000126	0.000234	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000124	0.000231	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT2—polycystic ovary syndrome	0.000123	0.000229	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000122	0.000227	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—YAP1—polycystic ovary syndrome	0.000121	0.000226	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SERPINE1—polycystic ovary syndrome	0.00012	0.000223	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NAMPT—polycystic ovary syndrome	0.000117	0.000217	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000116	0.000216	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000115	0.000214	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000115	0.000214	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000115	0.000214	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000114	0.000213	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000109	0.000202	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000107	0.000199	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AR—polycystic ovary syndrome	0.000106	0.000197	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NCOR1—polycystic ovary syndrome	9.27e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TH—polycystic ovary syndrome	9.27e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC2A4—polycystic ovary syndrome	9.01e-05	0.000168	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR3C1—polycystic ovary syndrome	8.58e-05	0.000159	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—polycystic ovary syndrome	8.48e-05	0.000158	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—polycystic ovary syndrome	8.05e-05	0.00015	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GNAS—polycystic ovary syndrome	7.57e-05	0.000141	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOR1—polycystic ovary syndrome	7.21e-05	0.000134	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A1—polycystic ovary syndrome	6.83e-05	0.000127	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPARG—polycystic ovary syndrome	6.64e-05	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—polycystic ovary syndrome	6.37e-05	0.000118	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SERPINE1—polycystic ovary syndrome	5.98e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—polycystic ovary syndrome	5.57e-05	0.000104	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPARG—polycystic ovary syndrome	5.16e-05	9.61e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—POMC—polycystic ovary syndrome	5.09e-05	9.47e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—INS—polycystic ovary syndrome	5.07e-05	9.42e-05	CbGpPWpGaD
